Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03221270 · ClinicalTrials.gov registry record · NA
Targeting Auditory Hallucinations With Alternating Current Stimulation
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03221270 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 25 participants.
The verdict
NCT03221270, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Investigating the effects of non-invasive transcranial alternating current stimulation (tACS) as a treatment for auditory hallucinations in patients with schizophrenia.
Interventions
- DEVICE tACS treatment week
- DEVICE tACS sham week
- DEVICE Maintenance tACS
- DEVICE Maintenance Sham tACS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2021-01-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03221270
The ClinicalTrials.gov registry entry for NCT03221270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which tACS treatment week is the first listed.
NCT03221270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03221270 about?
NCT03221270 is a clinical study titled "Targeting Auditory Hallucinations With Alternating Current Stimulation". Investigating the effects of non-invasive transcranial alternating current stimulation (tACS) as a treatment for auditory hallucinations in patients with schizophrenia.
What is the current status of trial NCT03221270?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-11-14. Estimated completion is 2021-01-05.
What interventions are being tested in trial NCT03221270?
The interventions under investigation include: tACS treatment week (DEVICE), tACS sham week (DEVICE), Maintenance tACS (DEVICE), Maintenance Sham tACS (DEVICE).
Who is sponsoring clinical trial NCT03221270?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.